Earnings (loss) per Share

Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income (loss) by the weighted average number of shares assuming dilution. Dilutive common shares outstanding is computed using the Treasury Stock method and reflects the additional shares that would be outstanding if dilutive stock options were exercised and restricted stock awards and warrants were settled for common shares during the period.

Earnings per share (in millions, except per share data):



	Three Months Ended					Six Months Ended
	July 1, 2017		July 2, 2016			July 1, 2017		July 2, 2016
Basic:
Net income (loss) attributable to the Company	$	17	$	(45	)	$	25	$	(71	)
Weighted-average shares outstanding	51,996,353		51,533,236			51,928,911		51,405,373
Basic earnings (loss) per share	$	0.33	$	(0.88	)	$	0.49	$	(1.38	)

Diluted:
Net income (loss) attributable to the Company	$	17	$	(45	)	$	25	$	(71	)
Weighted-average shares outstanding	51,996,353		51,533,236			51,928,911		51,405,373
Dilutive shares⁽¹⁾	1,132,304		—			1,109,045		—
Diluted weighted-average shares outstanding	53,128,657		51,533,236			53,037,956		51,405,373
Diluted earnings (loss) per share	$	0.32	$	(0.88	)	$	0.48	$	(1.38	)

(1) Due to net losses in the second quarter and fiscal year-to-date of 2016, options, awards and warrants were anti-dilutive and therefore excluded from the earnings per share calculation.

There were 273,216 outstanding options and awards to purchase common shares that were anti-dilutive and excluded from the second quarter earnings per share calculation as of July 1, 2017 compared to 1,313,435 as of July 2, 2016. There were 701,272 outstanding options and awards to purchase common shares that were anti-dilutive and excluded from the six months ended earnings per share calculation as of July 1, 2017 compared to 1,356,668 as of July 2, 2016. Anti-dilutive securities consist primarily of stock appreciation rights (“SARs”) with an exercise price greater than the average market closing price of the Class A common stock.